
Postingan

Mercury77
#ModernaQ3VaccineSales
My take on Moderna (MRNA) Q3:
I am leaning YES on beating earnings. The bar is very low — consensus is -$1.10 EPS on ~$890M revenue, vs -$0.51 on $1.02B last year. In Q2 they already beat with -$1.97 on $145M revenue vs $103M expected.
The real story is not COVID anymore, it's the cancer vaccine data. That is why the stock is up almost 8x from its low this year.
Penafian: Konten OKX Orbit ini hanya disediakan untuk tujuan informasi. Selengkapnya
Balasan
Belum ada komentar. Jadilah yang pertama membalas!
Berita pasar hari ini
1#NVIDIA menargetkan rekor pendapatan kuartalan senilai seratus miliar dolar


2#Anthropic memulai roadshow IPO, valuasi naik kembali menjadi 1,8 triliun dolar AS



3#BTC terus turun, dana keuangan dan institusi masih melakukan alokasi

